Sinovac will propose a vaccine plan for clinical research and emergency use targeting Gamma and variants varian Delta. Sinovac CEO Yin Weidong said this vaccine would be different from the previously produced CoronaVac.
Quoted from Global Times, this new product, if successfully developed and approved by other countries, will be supplied depending on the variant that dominates in that country.
“Sinovac capable of producing different types of vaccines targeting different variants,” Yin said.
In a document, Yin said that Sinovac had also completed research on CoronaVac booster injections, which showed that booster injections could rapidly increase levels of neutralizing antibodies within one week. The results will soon be published in the journal Science.
Zhang Yuntao, Vice President of China National Biotech Group, a subsidiary of Sinopharm, also mentioned at a forum that Sinopharm will submit an application for clinical research on a vaccine against the Delta variant.
Watch Videos”Sinovac Ready to Make Special Vaccines to Face A Number of Corona Variants“
[Gambas:Video 20detik]
(kna / kna)
– .
